XNAS
ASTH
Market cap1.67bUSD
Oct 08, Last price
35.87USD
1D
-3.42%
1Q
-23.48%
Jan 2017
378.27%
Name
Apollo Medical Holdings Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Apollo Medical Holdings, Inc. (AMEH) is a technology-driven healthcare firm that centers its operations around its medical practitioners to deliver comprehensive healthcare solutions. The company utilizes its proprietary platform for population health management and care provisioning, running an integrated, value-focused healthcare model. This framework enables its network of practitioners to furnish comprehensive patient care. AMEH provides meticulously coordinated care for a wide array of parties, including individual patients, their relatives, general practitioners, medical specialists, acute care facilities, other inpatient settings, various physician organizations, and health insurance providers. Its clinical team includes general practitioners, specialized doctors, and hospital-based physicians. Primarily serving the California populace, it attends to patients with diverse insurance coverage—including private plans, government programs like Medicare and Medicaid, and HMOs—as well as those who are uninsured. Founded in 1994, the company maintains its corporate headquarters in Alhambra, California.
Key people
Kenneth T. Sim
Executive Chairman of the Board, Co-Chief Executive Officer · since 2019
Hing Ang
Chief Operating Officer · since 2017
Adrian C. Vazquez
Co-Chief Medical Officer · since 2017
Albert Waichow Young
Co-Chief Medical Officer · since 2017
Director · since 2019
Thomas S. Lam
President, Co-Chief Executive Officer, Director · since 2019
Linda Marsh
Director · since 2019
Matthew Mazdyasni
Director · since 2019
Ernest A. Bates
Independent Director · since 2018
Michael F. Eng
Independent Director · since 2017
Independent Director · since 2016
Mitchell W. Kitayama
Lead Independent Director · since 2017
David G. Schmidt
Independent Director · since 2013
Independent Director · since 2017
Legal address
C/O Registered Agent Solutions, Inc.
1679 South DuPont Highway
Suite 100
Dover, DE 19901
US
1679 South DuPont Highway
Suite 100
Dover, DE 19901
US
Headquarters
700 North Brand Boulevard
Suite 220
Glendale, CA 91203
US
Suite 220
Glendale, CA 91203
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||